Changes in the structure of pathogens of calculous pyelonephritis complicated with diabetes mellitus type ii, in the hospital urology of the city of Volgograd


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Among the diseases complicating the course of calculous pyelonephritis, are among the leaders of diabetes mellitus, which is associated with reduced immune response, deterioration of renal hemodynamics, the reduced sensitivity to antibacterial drugs. The purpose of the study is to improve the results of treatment of patients with calculous pyelonephritis and diabetes mellitus type 2. The materials and methods of research. We studied 179 people. This was a retrospective pharmaco-epidemiological analysis of medical records of patients who were treated in 2009 and 2013, in hospital of Volgograd. Women in the study was greater than 99(by 55.4%), males - 80 (44,6%). All patients underwent standard clinical examination, with mandatory bacteriological urine analysis, ultrasound study of kidneys. Results. During the observation period of 2009 and 2013 in patients with calculous pyelonephritis and type 2 diabetes, the major pathogens were representatives of the family Enterobacteriaceae. E.coli strains are constituted - 12 (54,5%), K. pneumoniae - 4 (18.1%) strains. In other etiologically significant microorganisms were Enterococcus spp. - 3 (13.6%) strain, P. aeruginosa - strain 2 (9%). The group of other (4.5%), we have carried pathogens isolated in the singular: Erobacter spp, S. aureus, and Klebsiella oxytoca. In patients with infection of the upper urinary tract and diabetes, there is a pronounced trend to decrease sensitivity to all groups of antibiotics. Sensitivity to unprotected penicillins and fluoroquinolones has decreased almost twice. Resistance to aminoglycosides of patients in this group increased by 23%. In patients with chronic calculous pyelonephritis and diabetes mellitus type 2 is high sensitivity of the main causative agents of infection to cephalosporins of the third and fourth generation (92%), protected beta-lactam penicillins (amoxicillin/clavulanate) - 86,4%, to carbapenemam is 89.4%. Conclusions. For the empiric treatment of infections of the upper urinary tract in patients with diabetes mellitus, can be recommended drugs: protected beta-lactam penicillins, cephalosporins of the third and fourth generation, carbapenem.

Full Text

Restricted Access

About the authors

V. I Petrov

The Volgograd State Medical University

A. Z Vinarov

SBEI HPE «First Moscow State Medical University n.a. I.M. Sechenov» of RMH

M. A Vekilyan

Non-government health care facility, Regional Hospital Volgograd-1 JSC «Russian Railway

Email: M.vekilyan@yandex.ru

N. G Kulchenko

People’s Friendship University of Russia

Email: kle-kni@mail.ru

References

  1. Аполихин О.И., Сивков А.В., Бешлиев Д.А., Солнцева Т.В., Комарова В.А., Анализ уронефрологической заболеваемости в Российской Федерации по данным официальной статистики. Экспериментальная и клиническая урология. 2011;1:4-11
  2. Аляев Ю.Г., Егшатян Л.В., Рапопорт Л.М., Ларцова Е.В. Гормонально-метаболические нарушения как системный фактор формирования мочевых камней. Урология. 2014;5:35-40
  3. Golden S.H., Robinson K.A., Saldanha I., Anton B., Ladenson P.W. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin. Endocrinol Metab. 2009;6:1853-1878.
  4. Wild S., Rolgloc G., Green A. Global prevalence of diabetes: estimates for the year 2000 and progections for 2030. Diabet Care. 2004;27:1047-1053.
  5. Дедов И.И. Консенсус совета экспертов Российской ассоциации эндокринологов (РАЭ) по инициации и интенсификации сахароснижающей терапии сахарного диабета 2 типа. Сахарный диабет. 2011;4:6-17
  6. Коган М.И., Набока Ю.Л., Гудима И.А. Эффективность антибактериальной терапии острого обструктивного пиелонефрита в зависимости от результатов бактериологического исследования мочи. Медицинский вестник Башкортостана. 2013;2(8):88-91
  7. Hess В. Metabolic syndrome, obesity and kidney stones. Arab. Journal of Urology. 2012;10(3):258-264.
  8. Gupta P., Gupta R., Jandial K., Samotra S., Rana V., Gupta R.,. Gupta S., Singh J. Emphysematous pyelonephritis in the setting of diabetes mellitus. J. Assoc. PhysiciansIndia. 2011;59:119-120.
  9. Перепанова Т.С., Козлов Р.С., Дехнич А.В., Палагин И.С., Шевелев А.Н., Волкова Е.М., Эгамбердиев Д.К. Выбор антимикробных препаратов при инфекции мочевыводящих путей. Урология. 2012;2:4-8
  10. Marien T., Mass A.Y., Shah O. Antimicrobial resistance patterns in cases of obstructive pyelonephritis secondary to stones. Urology. 2015;85(1):64-72.
  11. Mohemid M.A., Salih A.M. Antibiotic Resistance Pattern of Bacteria Isolated from Patients of Urinary Tract Infections in Iraq. Open Journal of Urology. 2013;3:124-131.
  12. Pearle M.S., Goldfarb D.S., Assimos D.G., Curhan G.,Denu-Ciocca C.J., Matlaga B.R., Monga M., Penniston K.L., Preminger G.M., Turk T.M., White J.R. Medical management of kidney stones: AUA guideline. J. Urol. 2014;192(2):316-324.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies